Caricamento...
miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3
BACKGROUND AND OBJECTIVES: The roles of microRNA(miR)‐106b‐5p in hepatocellular carcinoma (HCC) remain unclear. We aimed here to investigate the clinical significance of miR‐106b‐5p expression in HCC and its underlying mechanisms. METHODS: Expression levels of miR‐106b‐5p in 108 HCC clinical samples...
Salvato in:
| Pubblicato in: | Cancer Med |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6825988/ https://ncbi.nlm.nih.gov/pubmed/31503422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2511 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|